Prevalence and Associated Factors to Human Papillomaviruses Types 16 and 18 among Malagasy Women in Fianarantsoa, Madagascar by Rakotozafy J C R & Ratiarson A C
Clinical Medicine and Diagnostics 2013, 3(3): 56-60 
DOI: 10.5923/j.cmd.20130303.02 
 
Prevalence and Associated Factors to Human 
Papillomaviruses Types 16 and 18 among Malagasy 
Women in Fianarantsoa, Madagascar 
Rakotozafy J. C. R.1, Ratiarson A. C.2,* 
1Laboratory of Molecular Biology, Center Hospital University of Fianarantsoa, Madagascar 
2Department of Biology, Laurentian University, Sudbury (ON), Canada 
 
Abstract  In this study, we analyzed by means of polymerase chain reaction (PCR) cerv ical specimens obtained from 
consenting women in Fianarantsoa, 1712 cerv ical specimens obtained from them. The data obtained were compiled to 
establish correlation and prevalence of HPV. Different PCR techniques were used to detect HPV in fection. Consensus primer 
sets MY and GP, and specific primers for HPV 16 and 18 were utilized to obtain the HPV typing. The result showed that 43 
specimensare positive by MY and GP that 22(51.16%) are HPV 16 and 15(34.88%) HPV18. 67.56% of the infected are about 
45 year old; 48.65% d ivorced; each woman had at least 2 d ifferent partners before marry ing and more of 4 partners after 
divorce. 29.73% of them are married and everyone had at least 4 partners before marrying. 21.62% are unmarried, with 
multip le partners. Our results indicated that HPV infections, especially those HPV 16 and 18 represent a significant public 
health in Madagascar. 




The cervical cancer is the second most frequent cancer of 
the woman in the world[1]. Every year, close to 500'000 new 
cases of cerv ical cancer d iagnosed are at the o rig in  of 
250'000 deaths[1]. About 80% of these cases occur in the 
developing countries, in part icular in Latin America and in 
sub-Saharan Africa, where the cervical cancer occupies the 
first  p lace[2]. Many  facto rs  o f ris k are bound to  the 
apparition of this cancer, as the mult iplicity of the sexual 
partners, the forwardness of the sexual intercourse and the 
first pregnancy, the low socioeconomic standard of living, 
the immune deficit or the tobacco addiction[3]. It has been 
established that the viral stub to high risk as the HPV16 and 
the HPV18 are the etiologic agent of the cervical cancer[4]. 
However, a lot of women infected by HPV v iruses to high 
risk are not going all to develop the cervical cancer[5] but to 
constitute the healthy carriers. In developing countries, the 
prophylactic vaccine is not accessible to the patients and 
otherwise, the access to the centers of basis care is pract ically 
impossible in  several cases. Otherwise, when the patients 
come to consult the physicians, in  general, the cancer Is  
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already to the advanced stage[3]. The necessity of the 
vaccine’s clarificat ion and the survey of the HPV type’s 
prevalence to high risk are primord ial of a future research 
putting in place prophylactic or therapeutic vaccines 
againstthe cervical cancer. 
In Madagascar, according to the statistics held by the 
oncology service of the CHU/HJRA in Antananarivo that 
was the unique center of oncology, the cervical cancer 
occupies the second place after the cancer of the breast at the 
woman with about 470 new cases per year (yearly report of 
activity 2011)[6]. Due to a lack o f tracking, but also because 
of the population sociocultural factors (the modesty, the 
level of education, the taboo…), the major part  of the cases is 
diagnosed to an advanced stage. 
The retrospective survey on the cervical cancer observed 
from 1992 to 2002 from 23 908 withdrawals addressed to the 
Institute Pasteur of Madagascar (IPM) for exam 
anatomopathological and 12 605 cervical s mears for 
cytological exam showed well that in  pathological anatomy, 
on 4 136 cases of d iagnosed cancer, 2 621 cases (63. 4%) 
have been observed at the woman. On the total of the 
confirmed  feminine cancers, 687 cases (26.2%) have a 
cervical localization. Three-quarters of the cervical cancer 
diagnosed are invasive with a middle age of 48. 2 years at the 
time of the diagnosis. The cytology of tracking doesn't have 
its diagnosed part that 74 cases of cancer. The precancerous 
lesions of the collar were 274 from which 61% diagnosed by 




In spite of th is strong cancer prevalence, little  study has 
been led to Madagascar concerning the cervical cancer 
prevalence or even less the prevalence of the HPV to high 
risk in  the cervical cancer. The factors of risks associated to 
the illness were not yet the subject of scientific  survey[6]. 
Currently, a national program of tracking by the visual 
inspection method to the acetic acid and the test of 
Papanicolaou (Pap smear) associated to the cryosurgery have 
been put in work but the results are not even available. 
Thus, this work will carry on the prevalence determination 
of HPV 16 and 18 to the women in rural environment of 
MatsiatraAmbony, Amoron'I Mania and Vatovavy 
Fitovinany in the province of Fianarantsoa using the 
conventional PCR skill. 
The choice of these three regions is based on the one hand 
to the conditions of life o f the women, and on the other hand 
the remoteness to the capital where is the unique national 
tracking center. 
The hope of Gardasil[HPV quadrivalent (types 6, 11, 16 
and 18) Vaccine Recombinant] could  not be realized in 
developing countries like Madagascar if the problem of the 
groups to high risk is not controlled through epidemiological 
studies on a big scale. 
Indeed, this survey that has been achieved in the province 
of Fianarantsoa (Madagascar) had for goal to search for the 
prevalence of HPV 16 and 18 by the molecular biology 
technique and the risk factors to the infection of the HPV in 
this region. 
2. Materials and Methods 
2.1. Study Population 
Women from selected rural health centers in the former 
province of Fianarantsoa (Madagascar) constituted the 
cohort of this study. The first step in the method consisted of 
an information session about cervical cancer and HPV being 
offered in each health center community. Women having 
suspected something wrong in their cerv ix were asked to 
volunteer to participate in the study by filling out a 
questionnaire requesting her age, education, sexual history, 
marital status, and tobacco consumption habits. Women at 
the beginning of pregnancy (less than 2 months) were also 
accepted into the study. The consent form, the questionnaire 
and the information pamphlet were written in the Malagasy 
language to facilitate the communication. A sterile 
disposable speculum was used for the gynecological exam. 
Cerv ical exfoliated cells were collected from all subjects by 
sampling the ectocervix and the endocervix using a 
cytobrush. The head of the cytobrush was kept in 5ml sterile 
phosphate buffered saline (PBS, pH 7.2) tube and frozen at 
-20 ̊C until DNA extraction. MY09/MY11 and GP5+/GP6+ 
consensus primer sets mediated PCR, amplifying DNA 
fragments in the conserved L1 region of approximately 
450bp and 150bp respectively. Further, type-specific PCR 
primer sets allow the identificat ion of individual genotypes 
have been widely used to study the natural history of human 
papillomaviruses (HPVs)[8][9][10]. All the specimens and 
corresponding questionnaires were carried out to the 
molecular biology laboratory in Fianarantsoa for analysis.  
2.2. DNA Preparation 
DNA from cerv ical cell samples was isolated as described 
previously[11][12]. Briefly, cervical cell suspensions were 
collected and treated with proteinase K (100 μg/ml) in lysis 
buffer (10mM Tris-HCl; pH 7.5, 1mM EDTA, pH 7.9; 0.5% 
SDS) overnight at 37°C. Standard phenol-chloroform 
extraction and ethanol precipitation were used for DNA 
purification. Pelleted DNA was resuspended in 50µL of 
deionized sterile water and stored at –20°C until further 
analysis. In order to determine the quality and the quantity of 
isolated DNA, each DNA was analyzed  by electrophoresis 
on 1% agarose gels stained with ethidium bromide and 
spectrophotometrically[13].  
2.3. Polymerase Chain Reaction (PCR) 
Each amplification reaction was carried out in  a total 
volume of 20µL overlaid with one drop of mineral oil and 
contained 10mM Tris–HCl (pH 8.3), 50mM KCl, 0.25U Taq 
DNA-polymerase, and 100–200ng DNA. The concentration 
of dNTPs and MgCl2 varied with each set of primers. Each 
PCR was carried out in DNA thermal cycler (Eppendorf).  
The conditions and the number o f denaturation–annealing
–extension cycles were different with each set of primers. 
Aliquots (10 µL) of each PCR product were resolved by 
electrophoresis in a 2% agarose gel stained with ethidium 
bromide. The amplified products were identified by UV 
irradiation of the gels, andphotographed by UVP 
TRANSILLUMINATOR (BIODOC-IT IMAG SYSTEM) 
(Figure 1 and Figure 2). 
 
Figure 1.  Electrophoresis of PCR products on 2% agarose gel (Image 
UVP Transilluminator, BIODOC-IT  IMAG SYSTEM); M: DNA marker 
(ΦX174 DNA/HaeIII Marker). (1) (2) (4): PCR with GP5+/GP6+ primers 
(142 bp), (3) (5) (6): PCR with MY09/MY11 primers (451bp) 
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Figure 2.  Electrophoresis of PCR products on 2% agarose gel (Image 
UVP Transilluminator, BIODOC-IT IMAG SYS); M: DNA marker 
(ΦX174 DNA/HaeIII Marker), HPV specific-primer directed PCR: (1) (2) 
(3) (4) PCR for HPV 16 (253 bp), (1’) (2’) (3’) (4’) PCR for HPV 18 (201 
bp) 
2.4. PCR Amplifications 
Every samples have been respectively amplified with the 
MY and GP primers. The samples which give some lanes on 
agarose gel have been dealt with the type-specific primers 
for HPV types 16 and 18. A ll primers used in this study are 
shown in Table 1 and Table 2. 
Table 1.  Consensus primer sequences for HPV DNA detection 
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2.5. PCR with MY09 and MY11 Consensus Primers 
The PCR mixture was complemented with 2.5 mM MgCl2,  
0.1 mM of each dNTP, 0.5 mM MY09 and MY11 primers. 
The DNA amplification was carried out during 30 cycles 
which included the denaturation at 92°C for 30 s, the 
annealing at 53°C fo r 30 s, and the primer extension at 72°C 
for 30 s. 
2.6. PCR with the GP5+ and GP6+ Consensus Primers 
The PCR mixture was complemented with 2.5 mM MgCl2,  
0.05 mM of each dNTP and 0.5 mM of GP5+ and GP6+ 
primers. The DNA amplificat ion was carried out during 40 
cycles that included the denaturation at 94°C fo r 30 s, the 
annealing at 45°C for 30 s and the primer extension at 72°C 
for 30 s[14],[15]. 
2.7. PCR with the type-s pecific Primers for HPV types 16 
and 18 
The PCR mixture was complemented with 1.5 mM MgCl2,  
0.15 mM of each dNTP and 0.15 mM of each primer. The 
DNA amplification  was carried out during 35 cycles that 
included the denaturation at 92°C for 15 s and the 
annealingand primer extension at 62°C for 4 min[16]. 
2.8. Statistical Analysis 
The statistical analysis of the qualitative and quantitative 
variables was either of mono-varied type, or of multivariate 
type using a software Epinfo version 6. The Student test was 
used for the comparison of the averages and the variances 
and the test of Chi-2[8] for the comparison between the rates 
and a significant value if p<0. 05.  
3. Results and Discussions 
The sensitization campaign  for the free t racking of the 
HPV, 1712 women have been appropriated. 
The average age of women appropriated is of 36.5 years 
(18 - 60) that means, in general, those women play a big ro le 
in the community and particu larly, in  the family. This 
number is meaningful in relation to the total number of the 
women in this reg ion that Fianarantsoa is the second 
province the more populated of Madagascar. 
This insufficiency to the number could be on the one hand, 
by the custom because according to the majority o f the 
different ethnic groups in this region, the history of "sex" is 
reserved to the more aged women. On the other hand, this 
number would also especially be able to the impact of the 
insufficiency of the sanitary infrastructure in th is region in 
rural environment that returns the population to get used 
from t ime to time to the traditional medicine. 
After the test of HPV DNA by PCR using consensus 
primers in the 1712 specimens, 43 (2.51%) and 39 (2. 27%) 
of specimens were respectively HPV positive in PCR using 
MY09/MY11 primers and GP5+/GP6+ primers (p˂ 0.05). 
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The result also show that the 39 positive in  GP are the same 
specimens positive of the 43 tested by MY. 
This difference can be translated that MY09/M11 primers 
are synthesized with several degenerate nucleotides in each 
primer and thus a mixture of 25 primers, capable of 
amplifying a wide range of HPV types[10]. The GP5+/GP6+ 
primers consist of fixed nucleotide sequence for each primer 
and detect a wide range of HPV types by using a lowered 
annealing temperature during PCR[13].Besides, the GP5+ 
and GP6+ primers are complementary to the part of the L1 
region located inside the sequence recognized by the MY 
primers[18]. Indeed, the survey took consideration the 
results gotten with the MY primers. 
HPV typing is of great importance for cervical cancer risk 
assessment, as well as planning individual treatment and 
vaccination strategies[15][16]. From those 43 specimens 
with positive result; we tested cervical specimens by PCR 
using type-specific p rimers HPV types 16 and 18. 22 
(51.16%) are HPV 16; 15 (34. 88%) are HPV 18 and the 
remain are other types since MY09/MY11 and GP5+/GP6+ 
can detect HPV 6, 11, 16, 18, 31 and 33 that why there is a 
mean ingful d ifference of the positivity rate between of HPV 
DNA by PCR using consensus and type-specific primers. 
On the 37 infected by HPV 16 and HPV 18; 25 (67.56%) 
are about 45 years old and 12 (32.44%) are between 30 to 44 
years old (p 0.05). 
Questionnaires of every infected woman showed that 18 
are divorced; each  woman had at least 2 different  partners 
before marrying and more of 4 partners after the divorce. 
Eleven of them are married and everyone had at least 4 
partners before marry ing. Eight are unmarried, they have 
multip le partners. The results also show that 29 on 37 
chewing tobacco (powder) at least 4 times per day. Three 
smoke at least 2 cigarettes per day.  
In this survey, the most elevated proportions of the HPV 
are diagnosed at the less aged women. These data coincide 
with those of Rakotondrajaona& al.[20] that find  a 
middleage enters 41 and 48 years, but defer those of the other 
countries in development where the cervical cancer is 
considered like an illness of the women  aged[21,22], or of 
Europe where the middle age is of 55 years[23]. This 
difference can explain itself by the slant of 
representativeness. 
Even that there is not until now scientific proof showing 
the relation between the infection of HPV and partner's 
multip licity, it is not necessary to disregard the high risk of 
the sexually transferable infection that encourages the 
infection of this virus. 
The tobacco addiction increases the cervical cancer by 
the presence of the carcinogenic molecule (cotinine) a 
metabolite product of the nicotine in tobacco, acting as a 
cocarcinogen in cervical cells already infected by HPV 16 or 
18 that had already the viral E6 and E7 oncogenes.  
4. Conclusions 
This survey confirms that the HPV infect ion exists at the 
Malagasy women and so that the survey is centred only on 
HPV16 and 18, the results well showed that the HPV 16 is 
the most frequent genotype. The majority of Malagasy 
women in rural environment took tobacco powder to help 
them all day for the hard  work in the rice field.The analysis 
of the subject sexual partner number or her sexual partners 
was not conclusive to the effect on HPV in fection in this 
survey. 
From th is survey, the feasibility in  Madagascar of a 
tracking program of cervical cancer by molecular biology 
technique constitutes the essential question; the necessity of 
such exam is indisputable if its realizat ion poses problems of 
practical application. 
In perspective, the analysis of all d ifferent HPV typeshigh 
risk will be important in order to determine the types the 
more frequent in Madagascar. 
Here are some recommendations made for the remainder 
of this research, and for future epidemio logy studies in 
Madagascar: struggle against tobacco and analysis of other 
HPV genotypes. 
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